1968
DOI: 10.1093/cvr/2.4.371
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Adrenergic Beta-Receptor Blocking Drugs on Blood Flow in the Coronary and Other Vascular Fields

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1969
1969
1989
1989

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The reduction in coronary flow due to an increase in coronary resis tance, which has been reported earlier with the use of f3-blocking agents, has been confirmed recently in patients (158) and attributed to a reduction in oxygen consumption deriving from reduction in heart rate and myocar dial contractile force (134,138,180,181). Two-thirds of this effect is attrib uted to f3-blockade and one-third to direct action, since it is obtained follow ing pre-treatment with reserpine and is also produced by D-propranolol, which is almost devoid of any adrenergic f3-blocking action (182).…”
Section: The B-adrenergic Blocking Agentsmentioning
confidence: 53%
“…The reduction in coronary flow due to an increase in coronary resis tance, which has been reported earlier with the use of f3-blocking agents, has been confirmed recently in patients (158) and attributed to a reduction in oxygen consumption deriving from reduction in heart rate and myocar dial contractile force (134,138,180,181). Two-thirds of this effect is attrib uted to f3-blockade and one-third to direct action, since it is obtained follow ing pre-treatment with reserpine and is also produced by D-propranolol, which is almost devoid of any adrenergic f3-blocking action (182).…”
Section: The B-adrenergic Blocking Agentsmentioning
confidence: 53%
“…Propranolol is known to reduce stress-related augmentation of cardiac rate, contractility, and work-all of which have prominent oxygen-sparing effects (Dwyer et al, 1968;Wiener et al, 1969). Some have suggested that this agent also directly affects the coronary circulation and reduces myocardial flow (Parratt, 1965;Wolfson et al, 1966;Nayler et al, 1967Nayler et al, , 1968Stein et al, 1968;Marchetti et al, 1972) and oxygen consumption (Jorgensen et al, 1973;Mueller et al, 1974) while increasing coronary resistance. Since the Received for publication 22 November 1977 effect of propranolol on heart rate also uniformly decreases oxygen requirements, significant direct coronary actions may be obscured.…”
mentioning
confidence: 99%